Prakash Kulkarni
- Co-authors
- Ravi SalgiaTakumi ShiraishiDebasish DuttaRobert H. GetzenbergSandeep A. ThoratAtish MohantyYu ZengArin Nam
- Topics
- Lung Cancer Treatments and Mutations (9 papers)Cancer Immunotherapy and Biomarkers (7 papers)Prostate Cancer Treatment and Research (7 papers)
- Partner nations
- United StatesIndiaJapan
In The Last Decade
Prakash Kulkarni
69 papers receiving 868 citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Molecular Biology 403
- Oncology 212
- Pulmonary and Respiratory Medicine 149
- Immunology 146
- Cancer Research 133
Countries citing papers authored by Prakash Kulkarni
This map shows the geographic impact of Prakash Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prakash Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prakash Kulkarni more than expected).
Fields of papers citing papers by Prakash Kulkarni
This network shows the impact of papers produced by Prakash Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prakash Kulkarni. The network helps show where Prakash Kulkarni may publish in the future.
Co-authorship network of co-authors of Prakash Kulkarni
This figure shows the co-authorship network connecting the top 25 collaborators of Prakash Kulkarni. A scholar is included among the top collaborators of Prakash Kulkarni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prakash Kulkarni. Prakash Kulkarni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapybreakdown → | 19 |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 8 | |
| 5 | 19 | |
| 6 | 31 | |
| 7 | 13 | |
| 8 | 5 | |
| 9 | 19 | |
| 10 | 3 | |
| 11 | 1 | |
| 12 | 10 | |
| 13 | 9 | |
| 14 | 31 | |
| 15 | 23 | |
| 16 | 14 | |
| 17 | 20 | |
| 18 | 12 | |
| 19 | 70 | |
| 20 | 10 |
About Prakash Kulkarni
Prakash Kulkarni is a scholar working on Oncology, Cancer Research and Information Systems, having authored 73 papers that have together received 908 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Prostate Cancer Treatment and Research (7 papers). The work is most often cited by research in Immunology and Allergy (62 citations), Cancer Research (133 citations) and Oncology (212 citations). Prakash Kulkarni has collaborated with scholars based in United States, India and Japan. Frequent co-authors include Ravi Salgia, Takumi Shiraishi, Debasish Dutta, Robert H. Getzenberg, Sandeep A. Thorat, Atish Mohanty, Yu Zeng, Arin Nam, Jun Luo and Sharad S. Singhal. Their work appears in journals such as Cancer Research, Scientific Reports and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.